Linghua Li

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

Yueping Li, Zhiwei Xie, Weiyin Lin et al. · Med · 2020 · 301 citations · Full text

Adult Patients, Covid-19 Pandemic, Antiviral Drug Development +9

Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection

Liang Shan, Kai Deng, Hongbo Gao et al. · Immunity · 2017 · 181 citations · Full text

Latent Hiv-1 Infection, Human Retrovirus, Immunology +6

An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)

Yueping Li, Zhiwei Xie, Weiyin Lin et al. · 2020 · 143 citations · Full text

Pharmacotherapy, Covid-19 Epidemiology, Antiviral Drug +16

Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L

Fei Yu, Ting Pan, Feng Huang et al. · 2020 · 123 citations · Full text

Microbial Pathogens, Viral Diagnostics, Glycobiology +19

TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb

Xiancai Ma, Tao Yang, Yuewen Luo et al. · eLife · 2019 · 108 citations · Full text

Human Retrovirus, Immunology, Antiviral Response +12